Mastezellen Bio Inc

Galaxy Diagnostics is a leading provider of advanced testing services for the diagnosis of flea and tick-borne diseases in both humans and pets. Their comprehensive range of tests includes the Bartonella Digital ePCR, Bartonella IFA Serology Panel, and Lyme Borrelia Nanotrap Antigen Test, which offer highly sensitive and accurate detection of infections. With a focus on research, education, and collaboration with leading institutions, Galaxy Diagnostics is dedicated to enhancing the clinical understanding of vector-borne diseases and improving patient outcomes. Utilizing state-of-the-art technologies and sample enrichment methodologies, Galaxy Diagnostics aims to confirm infections that are often missed by conventional testing methods. Their commitment to advancing the field of Bartonella and Borrelia research has established them as trusted leaders in the medical, public health, and veterinary communities. With a mission to go beyond the limits of detection, Galaxy Diagnostics is at the forefront of diagnosing and raising awareness about these important vector-borne diseases.Generated from the website

Curie Co Inc is a leading industrial biotechnology company based in Research Triangle Park, North Carolina. Positioned at the forefront of innovation, they specialize in developing cutting-edge solutions for various industries. With a focus on partnership opportunities and press inquiries, Curie Co Inc invites collaboration and engagement from those interested in joining their journey of elegant evolution in the field of biotechnology.Generated from the website

Altis Biosystems is a pioneering company based in Durham, NC, that specializes in developing innovative in vitro models for pre-clinical drug discovery. Their RepliGut Systems, derived from adult human donor stem cells, accurately replicate the complex structure of the human small intestine and colonic epithelium, providing valuable data insights and rapid screening capabilities for drug development. By capturing the complexity of the human gut, Altis Biosystems aims to enable pharmaceutical companies to identify effective compounds earlier in the drug development process, reducing the need for animal testing and making the process faster, cheaper, and safer. Their user-friendly and scalable RepliGut models offer a wealth of physiologically relevant preclinical insights, ultimately enhancing the performance of clinical trials and paving the way for more effective compound screening and disease modeling.Generated from the website